-
Product Name
Zilovertamab (Synonyms: CIRMTUZUMAB)
- Documents
-
Description
Anti-ROR1 Antibody (Zilovertamab)
-
Tested applications
ELISA
-
Species reactivity
Human ROR1
-
Alternative names
CIRMTUZUMAB antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-ROR1 Antibody (zilovertamab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-ROR1 Antibody (zilovertamab) is 98.21%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human ROR1 His at 2 ug/mL can bind Anti-ROR1 Antibody (zilovertamab), EC50=0.00283 ug/mL.
Bioactivity: FACS
A549 cells were stained with Anti-ROR1 Antibody (zilovertamab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.002776 ug/ml.
Function: Internalization
zilovertamab by Human ROR1 HEK293T cells increased with the increase of antibody concentration, and the Internalization Rate (%) reached 72%.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"